
|Articles|October 13, 2019
AAO 2019 Retina Street Team: Key takeaways
Author(s)AAO 2019 Retina Street Team
Advertisement
Judy E. Kim, MD; David M. Brown, MD; and Charlie C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.
Judy E. Kim, MD; David M. Brown, MD; and Charles C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
2
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
3
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
4
REGENXBIO doses first patient in NAAVIGATE, phase 2b/3 sura-vec trial for diabetic retinopathy
5























